ZA969645B - Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. - Google Patents

Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.

Info

Publication number
ZA969645B
ZA969645B ZA9609645A ZA969645A ZA969645B ZA 969645 B ZA969645 B ZA 969645B ZA 9609645 A ZA9609645 A ZA 9609645A ZA 969645 A ZA969645 A ZA 969645A ZA 969645 B ZA969645 B ZA 969645B
Authority
ZA
South Africa
Prior art keywords
prepare
novel intermediates
bridged bisindolylmaleimides
bisindolylmaleimides
bridged
Prior art date
Application number
ZA9609645A
Other languages
English (en)
Inventor
Margaret Mary Faul
Christine Ann Krumrich
Junior Leonard Larr Winneroski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA969645(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA969645B publication Critical patent/ZA969645B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
ZA9609645A 1995-11-20 1996-11-18 Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. ZA969645B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20

Publications (1)

Publication Number Publication Date
ZA969645B true ZA969645B (en) 1998-05-18

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609645A ZA969645B (en) 1995-11-20 1996-11-18 Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.

Country Status (31)

Country Link
EP (1) EP0776899B1 (xx)
JP (2) JP4100708B2 (xx)
KR (1) KR100342142B1 (xx)
CN (1) CN1066734C (xx)
AR (2) AR004718A1 (xx)
AT (1) ATE191219T1 (xx)
AU (1) AU701659B2 (xx)
BR (1) BR9611709A (xx)
CA (1) CA2237401C (xx)
CO (1) CO4750824A1 (xx)
CZ (1) CZ150398A3 (xx)
DE (1) DE69607443T2 (xx)
DK (1) DK0776899T3 (xx)
EA (1) EA000639B1 (xx)
ES (1) ES2145978T3 (xx)
GR (1) GR3033729T3 (xx)
HU (1) HU225716B1 (xx)
IL (1) IL124415A (xx)
MX (1) MX9803791A (xx)
MY (1) MY118946A (xx)
NO (1) NO310195B1 (xx)
NZ (1) NZ323282A (xx)
PE (1) PE17998A1 (xx)
PL (1) PL184728B1 (xx)
PT (1) PT776899E (xx)
TR (1) TR199800876T2 (xx)
TW (1) TW371661B (xx)
UA (1) UA56145C2 (xx)
WO (1) WO1997019080A1 (xx)
YU (1) YU49316B (xx)
ZA (1) ZA969645B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
EP1070068B2 (en) * 1998-03-13 2007-01-17 The University Of British Columbia Granulatimide derivatives for use in cancer treatment
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2023192984A1 (en) * 2022-03-31 2023-10-05 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
HU219709B (hu) * 1993-12-07 2001-06-28 Eli Lilly And Co. Proteinkináz C gátló hatású kondenzált indolszármazékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
JP2008138006A (ja) 2008-06-19
PT776899E (pt) 2000-08-31
TW371661B (en) 1999-10-11
KR19990067600A (ko) 1999-08-25
EA000639B1 (ru) 1999-12-29
AU701659B2 (en) 1999-02-04
DE69607443T2 (de) 2000-08-10
NZ323282A (en) 1999-01-28
JP2000500496A (ja) 2000-01-18
JP4100708B2 (ja) 2008-06-11
CA2237401C (en) 2003-10-21
DE69607443D1 (de) 2000-05-04
CN1066734C (zh) 2001-06-06
GR3033729T3 (en) 2000-10-31
YU61096A (sh) 1999-03-04
EP0776899B1 (en) 2000-03-29
AR004718A1 (es) 1999-03-10
CN1207740A (zh) 1999-02-10
CZ150398A3 (cs) 1998-12-16
DK0776899T3 (da) 2000-07-10
BR9611709A (pt) 1999-02-23
AR004719A1 (es) 1999-03-10
PL184728B1 (pl) 2002-12-31
UA56145C2 (uk) 2003-05-15
KR100342142B1 (ko) 2002-08-22
HUP9901975A3 (en) 2000-01-28
ES2145978T3 (es) 2000-07-16
EP0776899A1 (en) 1997-06-04
WO1997019080A1 (en) 1997-05-29
ATE191219T1 (de) 2000-04-15
CA2237401A1 (en) 1997-05-29
MY118946A (en) 2005-02-28
MX9803791A (es) 1998-09-30
HU225716B1 (en) 2007-07-30
PE17998A1 (es) 1998-04-20
TR199800876T2 (xx) 1998-08-21
IL124415A (en) 2003-11-23
YU49316B (sh) 2005-06-10
PL326753A1 (en) 1998-10-26
NO982105D0 (no) 1998-05-08
IL124415A0 (en) 1998-12-06
NO982105L (no) 1998-05-08
HUP9901975A2 (hu) 1999-11-29
EA199800368A1 (ru) 1998-12-24
AU7738896A (en) 1997-06-11
NO310195B1 (no) 2001-06-05
CO4750824A1 (es) 1999-03-31

Similar Documents

Publication Publication Date Title
IL116770A0 (en) 2, 8-disubstituted quinazolinones their preparation and use
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
EP0613884A3 (de) Dialkyl-1-H-3-(2,4-dimethylphenyl)-pyrrolidin-2,4-dione, ihre Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Herbizide.
ZA964711B (en) Novel compounds, the preparation and use thereof.
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU4329396A (en) Use of 3,4-diphenylchromans
EP0669332A3 (de) Substituierte Naphthyridine und deren herbizide Verwendung.
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
AU2490495A (en) Insecticidal N,N'-disubstituted-N-N'-diacylhydrazines
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
HUP0000498A3 (en) Novel calpaines, production and use thereof
ZA961972B (en) 3-Aryluracils and intermediates for their preparation.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
EP0786248A3 (fr) Utilisation du dithioacétate de S,S'-éthylidène à titre d'ingrédient parfumant et aromatisant
GB2291875B (en) Azodyes and intermediates,their production and use
IL110569A0 (en) Intermediate to 4,4'-diamino-3-methyl- diphenylether-bis-maleimide
AU6925496A (en) 1,3,4-oxadiazolin-2-ones and their use as pesticides
Jonasson Väg-och tågtrafikbuller. En översikt över olika fenomen.
IE892053L (en) 1,4-dihydropyridine-threonines and intermediates.
ZA971137B (en) New intermediates to pesticides.
ZA959601B (en) 2-[1', 2', 4'-triazol-3'-yloxymethylene] anilides their preparation and their use